Evaluation of Antidepressant Activity of Emblica officinalis in Albino Wistar Rats

Background

Major depressive disorder is a multifactorial neuropsychiatric condition characterized by incomplete therapeutic response and tolerability issues associated with currently available antidepressant drugs. This has stimulated interest in plant-derived agents with multi-targeted biological activity. Emblica officinalis (Amla), a traditional Rasayana drug, is rich in polyphenols and related phytoconstituents with reported antioxidant and neuromodulatory properties, suggesting potential relevance in depressive disorders.

Aim

To evaluate the antidepressant-like activity of the ethanolic extract and successive polarity-based solvent fractions of Emblica officinalis using validated rodent behavioural models.

Materials and Methods

Fresh fruits of Emblica officinalis were subjected to Soxhlet extraction with ethanol, followed by successive fractionation into petroleum ether, benzene, ethyl acetate, acetone, and methanol fractions. Adult albino Wistar rats were treated orally for 10 consecutive days. Antidepressant-like activity was assessed using the Forced Swim Test, Tail Suspension Test, and Cook’s Pole Climbing Apparatus. Behavioural parameters included immobility time, latency to climb, and conditioned avoidance responses. Data were analysed using one-way ANOVA followed by Tukey’s post hoc test.

Results

Imipramine produced a marked reduction in immobility in both despair-based models, validating the experimental design. Among the test samples, the ethyl acetate fraction demonstrated the most pronounced antidepressant-like activity in the Forced Swim and Tail Suspension tests, followed by the methanol fraction and the crude ethanolic extract. In the Cook’s Pole Climbing Apparatus, the crude ethanolic extract produced the greatest modulation of conditioned avoidance and escape behaviour, with comparatively smaller but significant effects observed for the methanol and ethyl acetate fractions.

Conclusion

Medium-polarity fractions of Emblica officinalis, particularly ethyl acetate and methanol fractions, exhibited consistent antidepressant-like effects in despair-based behavioural models, while the crude ethanolic extract showed broader behavioural modulation. These findings support further phytochemical standardisation and mechanistic evaluation of Emblica officinalis fractions as potential leads for plant-based antidepressant research.